aTyr Pharma Inc (LIFE)
2.00
+0.07
(+3.63%)
USD |
NASDAQ |
May 17, 16:00
2.00
0.00 (0.00%)
After-Hours: 20:00
aTyr Pharma Accounts Payable (Quarterly): 4.893M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 4.893M |
| December 31, 2023 | 3.529M |
| September 30, 2023 | 2.043M |
| June 30, 2023 | 0.516M |
| March 31, 2023 | 3.965M |
| December 31, 2022 | 3.106M |
| September 30, 2022 | 3.129M |
| June 30, 2022 | 1.674M |
| March 31, 2022 | 1.563M |
| December 31, 2021 | 1.031M |
| September 30, 2021 | 0.90M |
| June 30, 2021 | 2.224M |
| March 31, 2021 | 1.161M |
| December 31, 2020 | 1.431M |
| September 30, 2020 | 1.352M |
| June 30, 2020 | 0.603M |
| March 31, 2020 | 0.748M |
| December 31, 2019 | 0.847M |
| September 30, 2019 | 1.324M |
| Date | Value |
|---|---|
| June 30, 2019 | 0.664M |
| March 31, 2019 | 0.834M |
| December 31, 2018 | 1.04M |
| September 30, 2018 | 0.599M |
| June 30, 2018 | 0.832M |
| March 31, 2018 | 1.462M |
| December 31, 2017 | 2.276M |
| September 30, 2017 | 3.592M |
| June 30, 2017 | 2.669M |
| March 31, 2017 | 1.246M |
| December 31, 2016 | 2.606M |
| September 30, 2016 | 3.565M |
| June 30, 2016 | 4.723M |
| March 31, 2016 | 5.876M |
| December 31, 2015 | 3.872M |
| September 30, 2015 | 1.59M |
| June 30, 2015 | 3.002M |
| March 31, 2015 | 3.168M |
| December 31, 2014 | 1.433M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.516M
Minimum
Jun 2023
4.893M
Maximum
Mar 2024
1.835M
Average
1.392M
Median
Accounts Payable (Quarterly) Benchmarks
| Vaxart Inc | 3.978M |
| Allogene Therapeutics Inc | 5.779M |
| AIM ImmunoTech Inc | 6.443M |
| Protalix BioTherapeutics Inc | 3.146M |
| Armata Pharmaceuticals Inc | 2.057M |